HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells <b><i>in vitro</i></b>: a comparative study using different statins

Franz Wiesbauer(University of Vienna), Johann Wojta(Medical University of Vienna), Gerlinde Zorn(Wilhelminen Hospital), Gerald Maurer(European Society of Radiology), Kurt Huber(Sigmund Freud Privatuniversität Wien), Christoph Kaun(University of Vienna)
British Journal of Pharmacology
January 1, 2002
10.1038/sj.bjp.0704454
Cited by 112

Related Papers

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
|Circulation|2011|1.1k
Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction
|New England Journal of Medicine|2011|877
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
|The Lancet|2018|793
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|755